CTOs on the Move

GrayBug

www.graybug.com

 
GrayBug® is a platform drug delivery company that is developing proprietary controlled release technologies for ophthalmic pharmaceutical indications. The company`s lead product is a polymer-drug biomolecular conjugate for the treatment of neovascular diseases, including age-related macular degeneration (AMD). GrayBug also has a proprietary platform technology that allows sustained drug delivery into various compartments of the eye while minimizing inflammation common with current controlled release technologies applied to the eye.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.graybug.com
  • 6411 Beckley St
    Baltimore, MD USA 21224
  • Phone: 443.853.2377

Executives

Name Title Contact Details

Funding

GrayBug raised $44.5M on 05/02/2016

Similar Companies

Southwest FLA Regional Imaging

Southwest FLA Regional Imaging is a Punta Gorda, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nurix Therapeutics

Nurix Therapeutics discovers drugs that harness the body`s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.

Bannerbio Nutraceutiocals Inc

Bannerbio Nutraceutiocals Inc is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FoldRx Pharmaceuticals

FoldRx Pharmaceuticals is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carolus Therapeutics

Carolus Therapeutics, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.